Skip to content

Clinical trials

Bile Duct Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bile Duct Neoplasms Country / region: South Korea Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20103
20111
20143
20162
20172
20181
20193
20204
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status6
Terminated5
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital4
Ajou University School of Medicine3
ASLAN Pharmaceuticals1
AstraZeneca1
Basilea Pharmaceutica1
CHANGHEE LEE1
Concordia Laboratories Inc.1
DualityBio Inc.1
Elevation Oncology1
Forma Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bile Duct Neoplasms24
Cholangiocarcinoma10
Pancreatic Neoplasms8
Biliary Tract Neoplasms6
Gallbladder Neoplasms5
Breast Neoplasms2
Choledocholithiasis2
Endometrial Neoplasms2
Esophageal Neoplasms2
Klatskin Tumor2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.